✦ LIBER ✦

Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C

✍ Scribed by David D. Douglas; Jorge Rakela; Hsiang Ju Lin; F. Blaine Hollinger; Howard F. Taswell; Albert J. Czaja; John B. Gross; Monte L. Anderson; Kevin Parent; C. Richard Fleming; John R. Cangemi; Peter C. O'Brien; Pauline E. Powis

Book ID: 112515334
Publisher: Springer US
Year: 1993
Tongue: English
Weight: 653 KB
Volume: 38
Category: Article
ISSN: 0163-2116
DOI: 10.1007/bf01316787

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High doses of recombinant α-interferon o

High doses of recombinant α-interferon or γ-interferon for chronic hepatitis C: A randomized, controlled trial

✍ Federico Sáez-royuela; Juan Carlos Porres; Alberto Moreno; Inmaculada Castillo; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

Chronic hepatitis C is often a progressive liver disease for which there is no satisfactory treatment. We studied the efficacy of recombinant a-interferon or y-interferon in the treatment of this disease in comparison with a control group. Thirty patients were randomly assigned to three groups. Ten

Randomized trial comparing three differe

Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C

✍ Liliana Chemello; Paola Bonetti; Luisa Cavalletto; Fabiola Talato; Valter Donado 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 769 KB

Alpha-interferon (IF"+) is an effective treatment for chronic hepatitis C, but only 20% to 30°C of patients are apparently cured with the currently recommended schedule of 3 MU given three times a week for 6 months. To evaluate the efficacy of more aggressive treatment regimens, we have conducted a

Treatment of chronic hepatitis C with re

Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial

✍ Giulio Diodati; Paola Bonetti; Franco Noventa; Carla Casarin; Massimo Rugge; Ser 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Sixty consecutive patients with chronic hepatitis C were included in a randomized controlled trial of recombinant human interferon-%, vs. no treatment. Treated patients received tapering doses of interferon thrice weekly for 1 yr. Twenty treated cases (66.7%) normalized serum aminotransferase levels

A prospective, randomized trial comparin

A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C

✍ M Rumi; E Del Ninno; M L Parravicini; R Romeo; R Soffredini; M F Donato; J Wilbe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

A prospective, randomized trial comparin

A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C

✍ M Rumi; E Del Ninno; ML Parravicini; R Romeo; R Soffredini; MF Donato; J Wilber; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Treatment of chronic hepatitis C with co

Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial

✍ M J Tong; K R Reddy; W M Lee; P J Pockros; J C Hoefs; E B Keeffe; F B Hollinger; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 2 views

AND THE CONSENSUS INTERFERON STUDY GROUP 15 tion. Efficacy was assessed by normalization of serum alanine This multicenter, randomized, controlled, double-blind, transaminase (ALT) concentration and decrease in serum hepphase III study in 704 patients with chronic hepatitis C infecatitis C virus (HC